The antiosteoporotic efficacy of intrave
✍
Terrence H. Diamond; Julie Winters; Angie Smith; Paul De Souza; John H. Kersley;
📂
Article
📅
2001
🏛
John Wiley and Sons
🌐
English
⚖ 96 KB
👁 2 views
## BACKGROUND. Prostate carcinoma therapy with combined androgen blockade may result in high bone-turnover with significant bone loss. This study was undertaken to evaluate the antiosteoporotic efficacy of intravenous pamidronate in a double blind, randomized, placebo-controlled, crossover study.